Ireland has not been involved in, or party to any stockpiling arrangements in relation to Remdesivir. We have however been a participant in the European Joint Procurement Exercise Framework Contract through the European Commission for Remdesivir. National guidance has been in place since March 2020 on the use of Remdesivir in Irish hospitals. The HSE monitor hospital demand for the drug based on admissions and predicted clinical need, and purchase stock as required. Supply is, and has been, adequate to meet demand and there is no requirement to stockpile.
Ireland continues to support the WHO Solidarity Trial, an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.